470 related articles for article (PubMed ID: 6797090)
1. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
[TBL] [Abstract][Full Text] [Related]
2. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
Chediak J; Peake I; Bloom A
Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
[TBL] [Abstract][Full Text] [Related]
3. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
Mason EC; Pepper DS; Griffin B
Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
[TBL] [Abstract][Full Text] [Related]
4. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat.
Winocour PD; Lopes-Virella M; Laimins M; Colwell JA
J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193
[TBL] [Abstract][Full Text] [Related]
5. In vivo interactions of autoantibodies to factor VIII with the factor VIII complex.
Allain JP; Croissant MP; Lerolle D; Houbouyan L; Zuzel M; Frommel D
Thromb Haemost; 1982 Oct; 48(2):142-5. PubMed ID: 6817443
[TBL] [Abstract][Full Text] [Related]
6. [Factor VIII complex activities in acute leukemia].
Pniejnia-Olszyński W; Lopaciuk S
Acta Haematol Pol; 1980; 11(4):239-47. PubMed ID: 6794320
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the pharmacokinetics of two von Willebrand factor concentrates [Biostate and AHF (High Purity)] in people with von Willebrand disorder. A randomised cross-over, multi-centre study.
Favaloro EJ; Lloyd J; Rowell J; Baker R; Rickard K; Kershaw G; Street A; Scarff K; Barrese G; Maher D; McLachlan AJ
Thromb Haemost; 2007 Jun; 97(6):922-30. PubMed ID: 17549293
[TBL] [Abstract][Full Text] [Related]
8. Factor VIII fractionation on aminohexyl Sepharose with possible reduction in hepatitis B antigen.
Austen DE; Smith JK
Thromb Haemost; 1982 Aug; 48(1):46-8. PubMed ID: 6813994
[TBL] [Abstract][Full Text] [Related]
9. The effect of storage of whole blood on the association of factor VIII-related antigen and factor VIII-coagulant antigen.
Hellings JA; Over J; van Mourik JA
Scand J Haematol; 1982 Nov; 29(5):353-62. PubMed ID: 6818685
[TBL] [Abstract][Full Text] [Related]
10. Development of a heat-treated factor VIII/von Willebrand factor concentrate prepared from heparinized plasma.
Palmer DS; Ganz PR; Perkins H; Rosborough D; Rock G
Thromb Haemost; 1990 Jun; 63(3):392-402. PubMed ID: 2119525
[TBL] [Abstract][Full Text] [Related]
11. von Willebrand factor contained in factor VIII concentrates of different purities supports platelet adhesion in blood samples from a heterogeneous group of patients with von Willebrand disease.
Escolar G; Carretero M; Magallón M; Quintana M; Arnau C; Castillo R; Aznar-Salatti J
Haematologica; 1998 Nov; 83(11):1009-14. PubMed ID: 9864923
[TBL] [Abstract][Full Text] [Related]
12. [Properties of factor VIII/von Willebrand factor in two highly-purified factor VIII concentrates, Hemofil M and Monoclate, using monoclonal antibodies].
Tanaka I; Yoshioka A; Shima M; Fujiwara T; Terada S; Nakai H; Miyata S; Sawamoto Y; Kamisue S; Fukui H
Rinsho Ketsueki; 1989 Jul; 30(7):951-7. PubMed ID: 2509762
[TBL] [Abstract][Full Text] [Related]
13. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
[TBL] [Abstract][Full Text] [Related]
14. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
Orthner CL
J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
[TBL] [Abstract][Full Text] [Related]
15. Factor VIII-related activities in therapeutic concentrates.
Barrowcliffe TW; Kemball-Cook G; Morris G; Holt JC; Furlong RA; Peake IR
J Lab Clin Med; 1981 Mar; 97(3):429-38. PubMed ID: 6780643
[TBL] [Abstract][Full Text] [Related]
16. Purified complex of factor VIII coagulant moiety and phospholipid: high factor VIII coagulant activity in factor VIII inhibitor plasma.
Muntean W
Wien Klin Wochenschr; 1984 Nov; 96(22):829-32. PubMed ID: 6442046
[TBL] [Abstract][Full Text] [Related]
17. Distribution of plasma fibronectin (cold-insoluble globulin) and components of the factor VIII complex after heparin-induced precipitation of plasma.
Amrani DL; Mosesson MW; Hoyer LW
Blood; 1982 Mar; 59(3):657-63. PubMed ID: 6800421
[TBL] [Abstract][Full Text] [Related]
18. [Determination of the factor VIII ristocetin cofactor (Willebrand factor) using a semi-quantitative slide test. Preliminary results].
Bogaty-Yver J; Musitelli JJ; Conard J; Horellou MH; Samama M
Ann Biol Clin (Paris); 1983; 41(5):319-24. PubMed ID: 6421207
[TBL] [Abstract][Full Text] [Related]
19. Standardization of Factor VIII-III. Establishment of a stable reference plasma for Factor VIII-related activities.
Barrowcliffe TW; Tydeman MS; Kirkwood TB; Thomas DP
Thromb Haemost; 1983 Oct; 50(3):690-6. PubMed ID: 6417818
[TBL] [Abstract][Full Text] [Related]
20. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
